UACJ Corporation (TSE:5741) last week reported its latest half-yearly results, which makes it a good time for investors to dive in and see if the business is performing in line with expectations. Statutory earnings per share fell badly short of expectations, coming in at JP¥52.81, some 37% below analyst forecasts, although revenues were okay, approximately in line with analyst estimates at JP¥743b. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.
Taking into account the latest results, UACJ's six analysts currently expect revenues in 2027 to be JP¥1.40t, approximately in line with the last 12 months. Statutory earnings per share are expected to nosedive 39% to JP¥261 in the same period. Before this earnings report, the analysts had been forecasting revenues of JP¥1.40t and earnings per share (EPS) of JP¥260 in 2027. The consensus analysts don't seem to have seen anything in these results that would have changed their view on the business, given there's been no major change to their estimates.
See our latest analysis for UACJ
The analysts reconfirmed their price target of JP¥3,005, showing that the business is executing well and in line with expectations. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. The most optimistic UACJ analyst has a price target of JP¥3,200 per share, while the most pessimistic values it at JP¥2,600. The narrow spread of estimates could suggest that the business' future is relatively easy to value, or thatthe analysts have a strong view on its prospects.
One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. We would highlight that UACJ's revenue growth is expected to slow, with the forecast 2.9% annualised growth rate until the end of 2027 being well below the historical 10% p.a. growth over the last five years. Compare this against other companies (with analyst forecasts) in the industry, which are in aggregate expected to see revenue growth of 3.8% annually. So it's pretty clear that, while revenue growth is expected to slow down, the wider industry is also expected to grow faster than UACJ.
The Bottom Line
The most obvious conclusion is that there's been no major change in the business' prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that UACJ's revenue is expected to perform worse than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.
With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have forecasts for UACJ going out to 2029, and you can see them free on our platform here.
Even so, be aware that UACJ is showing 3 warning signs in our investment analysis , and 2 of those don't sit too well with us...
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.